Multimodal Therapy in Anisometropic Amblyopia (NCT07093840) | Clinical Trial Compass
CompletedNot Applicable
Multimodal Therapy in Anisometropic Amblyopia
Turkey (Türkiye)29 participantsStarted 2023-07-29
Plain-language summary
This study aims to evaluate whether a six-month app-based visual therapy program, called AmblyoPlay, can improve visual acuity, oculomotor skills, and balance in children with anisometropic amblyopia (a type of "lazy eye" caused by unequal refractive errors between the eyes). The therapy uses interactive games to train visual and motor functions. The study compares children who receive this therapy with a control group of children who do not receive any intervention. Researchers aim to explore the effectiveness of a multidisciplinary, technology-assisted approach that addresses visual and sensorimotor functions through an integrated, child-centered perspective.
Who can participate
Age range
6 Years – 13 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age between 7 and 13 years
Diagnosed with anisometropic amblyopia according to AAO (American Academy of Ophthalmology) guidelines
No vestibular pathology within the past 6 months
No cognitive or mental impairments
No history of prior ophthalmologic treatment for amblyopia
Able to adhere to the treatment protocol
Written informed consent obtained from a parent or legal guardian
Exclusion Criteria:
* Age outside the range of 7 to 13 years
Presence of strabismus or other ocular pathologies (e.g., cataract, retinal disease)
Diagnosed neurological, developmental, or psychiatric disorders
Use of medications that may affect vision or balance
Participation in another clinical trial within the past 6 months
Inability to attend scheduled follow-up evaluations or comply with study procedures
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Visual acuity
Timeframe: Baseline, 1 month, 3 months, and 6 months